Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study

Overview of attention for article published in Lancet Oncology, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 7 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 87 X users

facebook: 1 Facebook page
reddit: 1 Redditor
guideline: 1 clinical guideline source

Readers on

mendeley: 61 Mendeley

So far, Altmetric has seen 7 news stories from 7 outlets.

Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets

AJMC, 12 Feb 2026

As pharmaceutical R

New Drug Approvals Are the Wrong Metric for Cancer Policy

Pediatric News , 20 Mar 2024

How should we define success in cancer policy — what should the endpoint be? It’s debatable.

New Drug Approvals Are the Wrong Metric for Cancer Policy

Medscape, 19 Mar 2024

How should we define success in cancer policy — what should the endpoint be? It's debatable.

Study reveals significant differences in cancer drug funding decisions in high-income countries

NewsBeezer, 03 Jun 2023

Despite the use of similar evaluation criteria when deciding whether to fund new cancer drugs, there are significant…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.